DROXIA 6337 (Droxia 400 MG)

Generic Name: hydroxyurea

Pill with imprint DROXIA 6337 is Orange, Capsule-shape and has been identified as Droxia 400 MG. It is supplied by Bristol-Myers Squibb.

Droxia is used in the treatment of anemia, sickle cell; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 400 MG is not a controlled substance under the Controlled Substances Act (CSA).

Images for DROXIA 6337

Droxia

Generic Name:

hydroxyurea

Imprint:

DROXIA 6337

Strength:

400 MG

Color:

Orange

Size:

22.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Antimetabolites

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Bristol-Myers Squibb

Inactive Ingredients:

citric acid monohydrate
gelatin
lactose
magnesium stearate
sodium phosphate
titanium dioxide
D&C Red No. 28
D&C Red No. 33
D&C Yellow No. 10
Note: Inactive ingredients may vary.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.